As per MRFR analysis, the South America Vascular Embolization Market Size was estimated at 190.17 (USD Million) in 2023. The South America Vascular Embolization Market Industry is expected to grow from 209(USD Million) in 2024 to 590 (USD Million) by 2035. The South America Vascular Embolization Market CAGR (growth rate) is expected to be around 9.894% during the forecast period (2025 - 2035).
The primary factors driving the South America Vascular Embolisation Market are the increasing prevalence of vascular diseases and the ageing population, which are leading to a higher incidence of conditions necessitating embolisation procedures. Furthermore, the region has seen a rise in the adoption of embolisation procedures as a result of the advancements in medical technology, particularly image-guided therapies and minimally invasive techniques. Governments are also promoting improvements to healthcare infrastructure in countries such as Argentina and Brazil, which enables improved access to advanced medical treatments.
Additionally, there are substantial opportunities to be investigated in the field of ambulatory care services, as healthcare providers are providing day surgeries and minimally invasive treatments, which are attracting a greater number of patients. The market is anticipated to expand due to the ongoing investment in healthcare systems, particularly with the introduction of new product lines that target specific vascular diseases. In recent years, there has been a distinct trend towards the integration of digital health technologies, including health information systems and telemedicine, to facilitate improved patient monitoring and follow-ups following embolism procedures.
Furthermore, the region is experiencing an increase in the prevalence of partnerships among key stakeholders, which is promoting the adoption of cutting-edge embolisation techniques and fostering innovation. In general, the vascular embolisation market in South America is undergoing a rapid transformation, which is being fueled by a convergence of healthcare requirements, technological advancements, and a commitment to enhancing patient outcomes.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Rising Incidence of Cardiovascular Diseases
The South America Vascular Embolization Market is experiencing growth driven by the increasing prevalence of cardiovascular diseases. According to the Pan American Health Organization, cardiovascular diseases account for approximately 30% of all deaths in South America. The demand for vascular embolization procedures is expected to rise as healthcare providers seek to address this urgent health concern. Organizations such as the Brazilian Society of Cardiology are actively promoting awareness and treatment options, leading to higher procedural rates. As the South American population continues to age, the need for effective treatment modalities, including vascular embolization, sits prominently within the agenda for healthcare systems, encouraging investments in related technologies and services.
Technological Advancements in Medical Devices
Technological innovation plays a significant role in driving the South America Vascular Embolization Market forward. The introduction of advanced embolization devices such as micro-coils, liquid embolics, and drug-eluting beads is enhancing treatment outcomes in vascular procedures. According to a report from ANVISA, the Brazilian Health Regulatory Agency, the clearance of novel embolization products has increased by 45% in recent years. This increase signifies a growing acceptance of innovative technologies by healthcare professionals in South America, pushing providers to adopt and invest in new therapies that enhance patient outcomes and reduce recovery times.
Growing Demand for Minimally Invasive Procedures
The demand for minimally invasive procedures is escalating within the South America Vascular Embolization Market Industry due to increased awareness about patient outcomes and recovery times. Research by the Latin American Society of Interventional Radiology indicates that patients prefer options that minimize hospital stays and lead to faster recovery periods. Hospitals and healthcare providers in South America are therefore investing in training staff and equipping facilities with necessary technologies to meet this growing demand. Reports suggest that minimally invasive vascular procedures have surged by over 25% in the last five years, further propelling the market forward. This trend is also supported by various surgical associations advocating for the integration of less invasive interventions in patient care.
The South America Vascular Embolization Market, particularly focusing on Embolization Technique, has been witnessing significant advancements largely driven by the increased prevalence of vascular diseases, coupled with a rise in minimally invasive procedures. The market offers distinct categories, primarily Coiling Devices and Non-coiling Devices, which cater to various clinical needs in vascular embolization. Coiling Devices have carved a significant position in the market as they efficiently treat certain types of aneurysms and vascular malformations, thanks to their ability to provide targeted treatment with reduced recovery time for patients. The effectiveness of these devices in occluding blood vessels enhances their adoption among healthcare providers.
Non-coiling Devices, on the other hand, represent a crucial part of the embolization landscape, serving a broad spectrum of applications, including uterine fibroids and benign prostatic hyperplasia. Their growing utilization can be linked to the increasing awareness and acceptance of embolization procedures among patients, fostering a conducive environment for the growth of both categories. Additionally, the South America region is progressively investing in healthcare infrastructure and innovation, leading to enhanced accessibility and adoption of advanced therapeutic techniques like those found in embolization.
Government initiatives aimed at improving healthcare outcomes can create new opportunities for market expansion in the embolization sector. Furthermore, the rising geriatric population in South America catalyzes market growth, as older adults are more susceptible to vascular disorders. Overall, the emphasis on patient safety and effective treatment modalities makes the Embolization Technique segment a vital area of interest in the South America Vascular Embolization Market, highlighting its potential to transform patient care outcomes.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The South America Vascular Embolization Market, particularly in the Application segment, showcases a diverse array of medical applications including Peripheral Vascular Disease, Oncology, Neurology, Urology, and other areas. Peripheral Vascular Disease has gained significant traction owing to the rising prevalence of lifestyle-related health issues, prompting increased demand for innovative treatment options. Oncology is also a crucial application, driven by the high incidence of cancer cases, necessitating advanced embolization techniques for effective tumor management.Neurology has emerged as a vital segment, where embolization is pivotal in treating conditions like arteriovenous malformations and aneurysms, reflecting the growing focus on neurological disorders in South America.
Urology presents substantial opportunities as well, particularly in managing renal tumors, enhancing patient outcomes through minimally invasive procedures. Other applications encompass a variety of vascular conditions, contributing to the overall market dynamics. As the healthcare infrastructure improves in South America, the continuous evolution of technology and techniques will drive further growth in this segment, aligning with the region's healthcare objectives and enhancing patient care across various medical fields.
The South America Vascular Embolization Market showcases significant regional dynamics, primarily driven by Brazil, Mexico, Argentina, and the Rest of South America. Brazil holds a substantial position in the market, being a key player due to its advanced healthcare infrastructure and a growing prevalence of vascular diseases. Meanwhile, Mexico is emerging as a vital market contributor, benefiting from increasing healthcare investments and a rising demand for minimally invasive procedures. Argentina also plays a pivotal role, particularly with its emphasis on modernizing healthcare services to improve patient outcomes.
The Rest of South America presents a diverse landscape, showcasing varied growth opportunities across different nations. Collectively, the South America Vascular Embolization Market reflects strong growth potential driven by factors such as technological advancements in embolization devices and increasing awareness of these procedures. Furthermore, challenges like regulatory approvals and market entry barriers persist, but the overall outlook remains positive, contributing to a vibrant market landscape in this region.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The South America Vascular Embolization Market is characterized by a competitive landscape that is rapidly evolving due to the increasing need for minimally invasive procedures, advancements in healthcare technology, and the rising prevalence of vascular diseases. As healthcare providers look for effective treatment options to improve patient outcomes, these factors influence the dynamics of the market. The competitive insights within this area are shaped by a diverse group of manufacturers and suppliers who are striving to innovate and differentiate their products. Companies are investing in research and development to enhance their offerings and capture a larger market share. Additionally, strategic partnerships and collaborations are frequently observed as companies aim to streamline their operations and extend their reach across the region.
AngioDynamics has established a strong presence in the South America Vascular Embolization Market, driven by its commitment to delivering high-quality medical devices for vascular interventions. The company focuses on innovation and has a diverse portfolio that addresses various vascular conditions, enhancing its appeal to healthcare professionals and patients. AngioDynamics is well-regarded for its cutting-edge technologies and solutions for embolization procedures, which have gained traction among medical practitioners in the region. The company's strengths lie in its strong brand recognition, a robust distribution network, and ongoing efforts in clinical education and training, which further reinforce its foothold in the market. By effectively addressing local healthcare challenges and leveraging its product advantages, AngioDynamics positions itself as a key player in this competitive landscape.
Volcano Corporation, with its specialized focus on advanced vascular imaging and therapeutic solutions, also plays a significant role in the South America Vascular Embolization Market. The company is renowned for its innovative products, such as interventional imaging systems and catheter-based systems, which are tailored to enhance procedural efficiency and precision during embolization treatments. Volcano Corporation has a noteworthy market presence due to its commitment to advancing clinical practices through technological innovations.
The company has solidified its strengths by continuously improving its product offerings based on feedback from healthcare professionals. In South America, Volcano Corporation's strategy may involve forming strategic alliances and conducting mergers and acquisitions with regional players to enhance its market position and expand its service capabilities. This approach not only broadens its product range but also reinforces its commitment to delivering superior healthcare solutions tailored to the unique needs of the South American medical landscape.
Key Companies in the South America Vascular Embolization Market Include
Recent developments in the South America Vascular Embolization Market have shown a significant increase in demand for minimally invasive procedures, driven largely by rising cases of vascular diseases and advancements in technology. Companies such as AngioDynamics and Boston Scientific are expanding their product lines to enhance embolization techniques. Notably, in August 2023, Abbott Laboratories launched a new embolization device specifically designed for use in the South American market, aiming to cater to the growing patient population.Currently, the market is witnessing substantial investments in Research and Development initiatives by firms like Medtronic and Stryker, focusing on innovative embolization solutions.
Additionally, in July 2023, Terumo announced a strategic partnership with a local medical institution in Brazil to improve patient access to their embolization products, emphasizing the collaborative approach to healthcare solutions in the region.Mergers and acquisitions have also been a focal point, with Merit Medical Systems acquiring a prominent vascular technology firm in June 2023 to strengthen its position in South America. This acquisition highlights the competitive landscape of the market as companies aim to consolidate resources and expertise. The overall growth in market valuation reflects the increasing recognition of vascular embolization treatments as vital in improving patient outcomes in South America.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 190.17(USD Million) |
| MARKET SIZE 2024 | 209.0(USD Million) |
| MARKET SIZE 2035 | 590.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.894% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | AngioDynamics, Volcano Corporation, Abbott Laboratories, Terumo, Boston Scientific, Stryker, Medtronic, John Wiley and Sons, Merit Medical Systems, Cook Medical, Neuronetics, Biosense Webster, Philips, BD, Cardinal Health |
| SEGMENTS COVERED | Embolization Technique, Application, Regional |
| KEY MARKET OPPORTUNITIES | Growing prevalence of vascular diseases, Increasing investment in healthcare infrastructure, Advancements in embolization technologies, Rising geriatric population, Expanding market for minimally invasive procedures |
| KEY MARKET DYNAMICS | Rising prevalence of vascular diseases, Increasing adoption of minimally invasive procedures, Advancements in embolization technologies, Growing awareness and early diagnosis, Strengthening healthcare infrastructure in regions |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
Frequently Asked Questions (FAQ) :
By 2024, the South America Vascular Embolization Market is expected to be valued at 209.0 USD Million.
The projected market size for the South America Vascular Embolization Market in 2035 is 590.0 USD Million.
The South America Vascular Embolization Market is expected to grow at a CAGR of 9.894% from 2025 to 2035.
In 2024, Brazil holds the largest market share, valued at 70.0 USD Million in the South America Vascular Embolization Market.
By 2035, the market size for non-coiling devices in the South America Vascular Embolization Market is expected to reach 358.0 USD Million.
Key players in the South America Vascular Embolization Market include AngioDynamics, Volcano Corporation, Abbott Laboratories, and Medtronic.
The expected market value for coiling devices in the South America Vascular Embolization Market by 2024 is 84.0 USD Million.
Mexico's market size in the South America Vascular Embolization Market is projected to reach 140.0 USD Million by 2035.
Key trends driving growth in the South America Vascular Embolization Market include technological advancements and increasing incidence of vascular diseases.
The market for the rest of South America is expected to grow to 170.0 USD Million by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
